文献速递神经介入DSACTMR

急性蛛网膜下腔出血中 hydrophilic 涂层血流导向装置在单抗血小板治疗下的动脉瘤治疗:三中心经验

Aneurysm Treatment in Acute SAH with Hydrophilic-Coated Flow Diverters under Single-Antiplatelet Therapy: A 3-Center Experience.
PubMed 文献 · AJNR Am J Neuroradiol · 2021-01-14

回顾性报告10例急性SAH患者共13个破裂颅内动脉瘤,使用 hydrophilic 涂层血流导向装置(p48 MW HPC 和 p64 MW HPC)在单抗血小板治疗下治疗,其中7个动脉瘤辅助弹簧圈栓塞。发生1例装置相关并发症(覆盖分支血栓形成),但随访DSA、CTA或MRA显示所有支架保持通畅。作者认为在严格选择的病例中,该方法似乎是一种选择。

要点

  • hydrophilic 涂层血流导向装置在单抗血小板治疗下可用于急性SAH破裂动脉瘤的治疗。
  • 10例患者中8例采用阿司匹林单抗方案,1例仅用普拉格雷,1例先用替罗非班后转为阿司匹林方案。
  • 1例发生装置相关并发症为覆盖分支血栓形成,但随访所有支架保持通畅。

关键影像表现/征象

  • 治疗动脉瘤类型包括4个血泡样、2个夹层和7个浆果样动脉瘤。
  • 7个动脉瘤接受辅助弹簧圈栓塞。
  • 1例发生装置相关并发症为覆盖分支血栓形成。
  • 随访DSA、CTA或MRA显示所有支架保持通畅。

临床应用与阅片要点

  • 对于急性SAH破裂动脉瘤,当双抗血小板治疗存在问题且血流导向装置为理想选择时,可考虑在单抗血小板治疗下使用 hydrophilic 涂层血流导向装置。
  • 8例患者接受阿司匹林单抗方案,1例仅用普拉格雷,1例先用替罗非班后转为阿司匹林单抗方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: In certain clinical circumstances, dual-antiplatelet therapy can be problematic in patients with acute SAH. In some aneurysms, however, flow-diverting stents are the ideal therapeutic option. We report our experience with ruptured intracranial aneurysms treated with flow diverters with hydrophilic coating (p48 MW HPC and p64 MW HPC) under single-antiplatelet therapy.

MATERIALS AND METHODS: Patients were treated with either flow-diverter placement alone or a flow diverter and additional coiling. Due to the severity of the hemorrhage, the potential for periprocedural rehemorrhage, and the potential for additional surgical interventions, a single-antiplatelet regimen was used in all patients.

RESULTS: Thirteen aneurysms were treated in 10 patients. The median age was 62 years; 5 patients were male. All had acute SAH due to aneurysm rupture. Four blood-blister, 2 dissecting, and 7 berrylike aneurysms were treated. Seven aneurysms were adjunctively coiled. Eight of the 10 patients received a single-antiplatelet protocol of aspirin, 1 patient was treated with prasugrel only, and 1 patient was treated with tirofiban first and then switched to the aspirin single-antiplatelet protocol. One device-related complication occurred, a thrombosis of an overstented branch. All stents, however, remained open at DSA, CTA, or MRA follow-up.

CONCLUSIONS: The implantation of flow diverters with reduced thrombogenicity due to hydrophilic surface coating under single-antiplatelet therapy seems to be an option in carefully selected cases of SAH due to aneurysm rupture.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Lobsien D, Clajus C, Behme D, et al. Aneurysm Treatment in Acute SAH with Hydrophilic-Coated Flow Diverters under Single-Antiplatelet Therapy: A 3-Center Experience. AJNR Am J Neuroradiol. 2021. PMID: 33446495. doi:10.3174/ajnr.A6942

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。